Studies performed on both the cancer cell panel and mixed ERBB2+/ERBB2− cultures demonstrated that pre-treatment with 929-B6 enhanced ERBB2-specific infectivity for lentiviral vectors pseudotyped with either VSV-G or VSV-Gmut + 929R. Here, ERBB2 is linked to cancer.